H.C. Wainwright Starts Lyra Therapeutics (LYRA) at Buy
Tweet
Share
E-mailGet Alerts LYRA Hot Sheet
Price: $0.50 --0%
Rating Summary:
1 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
1 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
H.C. Wainwright analyst Matthew Caufield initiates coverage on Lyra Therapeutics (NASDAQ: LYRA) with a Buy rating and a price target of $12.00.
For an analyst ratings summary and ratings history on Lyra Therapeutics click here. For more ratings news on Lyra Therapeutics click here.
Shares of Lyra Therapeutics closed at $3.36 yesterday.
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Citi Starts Federal Signal (FSS) at Buy
- Goldman Sachs Resumes Luxshare Precision (002475:CH) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
